Skip to content

A PET study of dopamine function in healthy subjects with hallucinations

A PET study of dopamine function in healthy subjects with hallucinations - dopamine function in healthy subjects with hallucinations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33598
Enrollment
20
Registered
2009-06-09
Start date
2009-06-11
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hallucinations psychosis

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Physically healthy subjects, evaluated by medical history, physical examination and screening laboratory tests Experiences hallucinations with a frequency of at least once a week. Total SPQ score lower than 25 No diagnosis on axis I or II based on DSM -IV criteria, confirmed by the CASH and the SCID II interview. Age between 18-60

Exclusion criteria

Exclusion criteria: Use of psychotropic medication within four weeks before the scanning Drug or alcohol-abuse over a period of three weeks prior to the experiment. More then 15 cigarettes and more then 6 cups of caffeine containing coffee, cola or tea. A history of neurological illness or other medical problems potentially having central nervous system sequellae. Pregnancy, breast feeding and use of inadequate anti-conception. Use of other medication potentially influencing cerebral blood flow. Claustrophobia Exposure to radioactivity leading to yearly cumulative dose of 10 mSv or more Metal objects in or around the body (braces, pacemaker, metal fragments); Exposure to radioactivity leading to a yearly cumulative dose of 10 mSv or more.

Design outcomes

Primary

MeasureTime frame
18F-Dopa influx rate constants (Ki) in subjects* striatal brain regions

Secondary

MeasureTime frame
18F-Dopa influx rate constants (Ki) in other brain regions

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)